Danish Firm Claims UK Biotech Used Trade Secrets

Acambis is alleged to have held talks to licence a rival's smallpox vaccine before withdrawing and using the trade secrets it had garnered to make its own version, according to a lawsuit filed against the British biotechnology company. The legal action from Bavarian Nordic claims that Acambis did not have its own version of a smallpox vaccine that can be used by the elderly and those with weak immune systems but "misappropriated" the Danish company's property to develop one.